Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
LEXICON PHARMACEUTICALS, INC. (LXRX)
Sector: Healthcare; Industry: Biotechnology

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-12-16 Artal International S.C.A. 10%-Owner, Director Buy 10,937,500 $3.20 $35,000,000 No
2014-11-26 Artal International S.C.A. 10%-Owner, Director Buy 149,253,731 $1.00 $150,000,000 No
2012-10-23 Artal International S.C.A. 10%-Owner, Director Buy 3,000,000 $2.25 $6,750,000 No

Insider Smart

Edesa Biotech, Inc. (EDSA) - President and CEO bought shares of EDSA in late May around $3, two weeks after their purchase, the stock jump to $9, very well timed buy.